CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients. Front Immunol
. 2023 May 1:14:1173035. doi: 10.3389/fimmu.2023.1173035. eCollection 2023.